Trademarkia Logo

Canada

C$
SYPEQIA
ADVERTISED

on 12 Feb 2025

Last Applicant/ Owned by

Sobi, Inc

77 4th Avenue, 3rd FloorWaltham, MA 02451

US

Serial Number

2308711 filed on 20th Jul 2021

Correspondent Address

FASKEN MARTINEAU DUMOULIN LLP

2900 - 550 BURRARD STREETVANCOUVER

BRITISH COLUMBIA

CA

V6C0A3

SYPEQIA

Trademark usage description

pharmaceutical preparations for the treatment of cancer, autoimmune disorders, inflammatory disorders concerning myelofibrosis and treatment and preve Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cancer, autoimmune disorders, inflammatory disorders concerning myelofibrosis and treatment and prevention of graft/host disorder.


Classification kind code

11

Class [044]
Providing healthcare information concerning of cancer, autoimmune disorders, inflammatory disorders concerning myelofibrosis and treatment and prevention of graft/host disorder.


Classification kind code

11

Mark Details


Serial Number

2308711

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 11th Jan 2023
Search Recorded
Submitted for opposition 20
on 11th Jan 2023
Examiner's First Report
Submitted for opposition 223
on 11th Jan 2023
Total Provisional Refusal
Submitted for opposition 256
on 25th Jul 2022
Notification of Possible Opposition Sent
Submitted for opposition 48
on 6th Dec 2021
Agent Changed
Submitted for opposition 257
on 23rd Sept 2021
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 23rd Sept 2021
Formalized
Submitted for opposition 1
on 23rd Sept 2021
Created
Submitted for opposition 228
on 20th Jul 2021
International Registration
Submitted for opposition 30
on 20th Jul 2021
Filed